Matches 1 - 50 out of 236 1 2 3 4 5 >


Match Document Document Title
DE102017002458B4 STRUCTURAL STEM CELLS FROM ADIPOSIVE FABRICS FOR USE IN THE TREATMENT OF TREATMENT-RESISTANT COMPLEX PERIANAL FISTLES AT MORBUS CROHN  
An augmented, allogeneic, adipose tissue-derived stromal stem cell for use in a method of treating a treatment-resistant complex perianal fistula comprising multiple ducts in a patient with...
DE102018211201B3 Sensor-effector cells for use in therapy  
The invention relates to the therapy of inflammation and / or cancer of the human or animal body and provides new cellular therapeutics that depend on a novel sensor-effector system in a...
DE102007004991B4 Use of RiV preparations for the treatment of cerebral infarction  
Use of BK-RiV preparations containing RiV particles with a size of 30 to 70 nm for the preparation of medicaments for the treatment of cerebral infarction, wherein the preparation of BK-RiV...
DE102016103555A1 Chinese medicine for the treatment of hyperostosis  
The present invention discloses a Chinese medicine for the treatment of hyperostosis, characterized in that it is made from the following main components by weight: sheep bones 20-30, Dioscorea...
DE19756864C5 Neural progenitor cells, methods for their preparation and their use for the therapy of neural defects  
Isolated, purified precursor cells with neuronal or glial properties from embryonic stem cells, containing at most about 15% primitive embryonic and non-neutral cells obtainable by the following...
DE102011117839A1 Preparation of hydrogels by Diels-Alder reaction  
Hydrogel, prepared by covalently crosslinking macromonomers by Diels-Alder [4 + 2] cycloaddition.
DE102011112955A1 A method for preparing a biological tissue construct and use of specific autologous cells obtained  
The process for producing a tissue construct used for medicinal purposes Endothelial Progenitor Cells (EPC), which have not been passaged several times and a content of EOEC (Early Outgrowth...
DE102011017208A1 Bivalirudin and other hirudin analogs for preservation of cellular functionality in clinical cell therapy  
The present invention relates to pharmaceutical compositions for cell therapy suitable for stem cell therapy non-embryonic stem cells and the only coagulation inhibiting component at least one...
DE102011001380B3 Composition, useful in the reconstitution of the immune defense of humans in the context of bone marrow transplantation, and for treating cancer, preferably leukemia, comprises a cell population obtained from bone marrow or blood  
Composition comprises a cell population obtained from a bone marrow or blood, where the cell population is depleted from T-cell receptor (TCR) alpha/beta-positive cells and cluster of...
DE102007008650B4 Cells for the therapy of heart  
Isolated mammalian cell, characterized by the following features: • the cell is a cell culture propagated in cell from a primary culture of a mammalian heart tissue taken from the tissue sample, •...
DE102010046218A1 Device, useful for treatment of injuries and illnesses of e.g. tendons and ligaments, comprises a layer system with at least three layers respectively comprising identical or different, dimensionally stable and biocompatible hydrogel  
Device comprises a layer system with at least three layers (1, 2, 4), where each layer comprises an identical or different, dimensionally stable and biocompatible hydrogel, and a cell-containing...
DE102009041885B4 Separation of Mesenchymal Stem Cells  
Use of binding to the cell surface markers CD146 binding molecules for the in vitro isolation and / or identification of mesenchymal stem cells with osteogenic differentiation potential of a...
DE202011108417U1 Local and dietary compositions without ether lipids, ether phospholipids, alkyl radicals, which are suitable for sensitive people  
Local, dietary compositions, which are characterized by the exclusion of ether lipids, ether phospholipids, alkyl radicals.
DE102006043625B4 A method for isolating and / or identifying mesenchymal stem cells (MSC)  
Use of antibodies or functional fragments thereof, produced by hybridoma cell lines that are selected from the group comprising, W8B2, 24D2, 28D4, or W4A5, for isolating and / or identifying...
DE102011052416A1 Wachstumsinhibierter hydroxyapatite, a process for its preparation and use  
The invention relates to wachstumsinhibierten hydroxyapatite for improving bone healing. This differs from the apatite previously been employed in that it releases in physiological solutions...
DE102010026500A1 A process for preparing autologous proteins  
In the method for preparing at least one therapeutically active protein or a protein mixture in a container, the container is filled with a body fluid and gold particles and incubated in this case...
DE102010023837A1 Isolation of mesenchymal stem cells  
The present invention relates to the use of a peptide selected from the group comprising laminin-1, collagen 1, collagen-3, Collagen 4, tenascin, thrombospondin-1, osteopontin, fibronectin,...
DE102011004987A1 Magnetic nanoparticles and group of nanoparticles  
For a particularly effective stem cell therapy is a nanoparticle comprising a first element consisting of a magnetic material, a carrier or covering element, consisting of a biodegradable...
DE102009040716B4 Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells  
Use of CD154 for the separation of activated conventional T-cells from an activated regulatory T cells (Treg) comprising a mixture of cells for providing a pure cell population of Treg.
DE102009040716A1 Use of CD154 for the identification and separation of non-regulatory T cells from a mixture with regulatory T cells  
The invention relates to the use of CD154 for the separation of activated conventional T-cells from an activated regulatory T cells (Treg) comprising mixture.
DE102009041885A1 Separation of Mesenchymal Stem Cells  
The present invention relates to the use of a binding molecule which binds to CD146 for the isolation and / or identification of stem cells with osteogenic differentiation potential. the invention...
DE202010011302U1 recipe Al  
A pharmaceutical composition comprising: Acidum formaicicum C30, Allium cepa C30, Arsenicum album C30, Arsenicum jodatum C30, Arum triphyllum C30, Arundo mauritanica C30, Dulcamara C30, Euphorbium...
DE202010011296U1 recipe Dentarell  
A pharmaceutical composition comprising: Chronic pulpitis Nosode D3, Kieferostitis Nosode D4, Follicul cyst Nosode D6, Caries Nosode D8, Kieferhöhlencyste Nosode D4, Periodontitis Nosode D10,...
DE102009017908A1 Vector for the transport of microbiological organisms to outbreaks  
The present invention relates to a protected and directional transport of bacteria or bacteria-derived active substance in human immune cells for the purpose of therapy and / or diagnosis and / or...
DE112008001609T5 Repair and treatment of bone defects by using a drug-induced cells, which is manufactured by hypertrophierungsfähigen chondrocytes, and a scaffold  
A method of inducing undifferentiated cells to induced osteoblasts, comprising: A) a step of providing a differentiation induced osteoblasts inducing agent which is obtained by culturing...
DE102008036060A1 Cell-based method and means for bone formation  
The invention relates to the use of in vitro or isolated in vitro differentiated osteoclasts for bone formation, in particular by in vivo application to trigger the bone formation by the...
DE102008020939A1 Preparing an extract e.g. for the regeneration of muscle tension, muscle-nerves and skin damage and scars and for the acceleration of wound healing, comprises extracting a body material of immunologically immature slaughtered animals  
Preparation of an extract in the form of powder, gel, ointment or liquid, comprises extracting a body material of immunologically immature slaughtered animals. ACTIVITY : Analgesic;...
DE102008007867A1 Processing of a thrombocyte-containing medium for lowering antigens, which are attached to medium, comprises adding medium to a slightly acidic environment, in which medium is filtered through an arrangement of hollow fiber membranes  
Processing of a thrombocyte-containing medium for lowering antigens, which are attached to the medium, comprises adding the medium to a slightly acidic environment, in which the medium is filtered...
DE102005023666B4 Using marmot oil for treating acne vulgaris, acne rosacea, phlebitis, herpes or external hemorrhoids  
Using marmot oil for treating acne vulgaris, acne rosacea, phlebitis, herpes or external hemorrhoids.
DE102007049402A1 Cosmetic process for increasing the pigmentation of skin using melanocyte  
The present invention proposes a cosmetic method for increasing the pigmentation of skin comprising the steps of applying melanocyte from root sheaths, which is one of a first area of ​​skin were...
DE102007045686A1 A process for preparing a free-flowing, powdered extracts by means of fluidized-bed drying  
The Invention includes a free-flowing extract vegetable, animal or other biological material, characterized in that the extract before or after drying Sodium stearyl coated and then to a mixture...
DE102007044487A1 Using the reverse cell differentiation program (OCDP) for the treatment of degenerated, properties under pathological state organs  
The This invention relates to a method of treating degenerative and / or being in the pathological state organs by use phenotypically stable ausdifferenzierender or differentiated, but...
DE112005003001B4 derived from human adipose multipotent stem cells and those containing cell therapeutics  
process for the production of adult stem cells, comprising culturing of human Adipose tissue-derived pellets in a medium containing N-acetyl-L-cysteine (NAC) and then collecting the cultured...
DE102007039429A1 A process for the activation of regulatory T cells  
The Invention relates to a method for the activation of regulatory T-cells (Treg cells) of the human or animal body, comprising a step of contacting the regulatory T cells (Treg cells) in a...
DE102007033072A1 Invention on expression and secretion of permanent canine interleukins  
The This invention relates to the production, specific expression and permanent secretion of canine interleukins, specifically interleukin-2 (cIL-2) or interleukin-12 (cIL-12), from transfected...
DE202008007923U1 suppository  
Suppository, characterized in that the suppository effective for smoking cessation Ingredients contains.
DE60037007T2 ENRICHED CENTRAL NERVOUS SYSTEM CELL POPULATIONS  
Enriched neural stem and progenitor cell populations, and methods for identifying, isolating and enriching for neural stem cells using reagent that bind to cell surface markers, are provided.
DE102007008650A1 Cells for the therapy of heart  
According to the invention fibroblast-like, obtained from myocardial biopsies cells CD90 negative, CD105 positive, CD105 positive, CD117-negative and / or are CD166-positive, as well as cell...
DE102006046959A1 Producing a standardized thrombocyte concentrate comprises separating a thrombocyte-rich fraction (TRF) from pooled donor material, testing and/or standardizing the TRF, and dividing the TRF into standardized units  
Producing a standardized thrombocyte concentrate comprises separating thrombocytes from pooled donor material, collecting a thrombocyte-rich fraction (TRF), testing and/or standardizing the TRF,...
DE202007015418U1 Preparation on the basis of marmot fat with different essential oils  
preparation on based marmot fat and essential oils, individually or mixed up to 90%, such as Rosmarienöl, Eucalyptus oil, Peppermint oil, tea tree oil, pine oil, orange oil, lemon oil and pepper oil.
DE102004034461B4 Gene therapy of solid tumors by retroviral, with arena virus glycoprotein pseudotyped vectors  
use of packaging cells, retroviral, with arena virus glycoprotein pseudotyped virions produce, for preparing a pharmaceutical A composition for gene therapy of solid tumors, characterized in that...
DE102006033168A1 Use of gelatin and a crosslinking agent for preparing a cross-linking therapeutic composition  
Around biological Regeneration method provide a therapeutic composition, which to a target area of ​​the body can be administered, whereby it is ensured that the suspended Cells and / or growth...
DE102006032887A1 Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote skin re-formation or regeneration  
Use of a preparation comprising calcium hydroxide, an oil from plant-, animal- or mineral origin or a synthetic oil obtained from such oils, to care skin wound and to promote the skin re-formation...
DE102006020444A1 Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors  
Transgenic mesenchymal stem cells stably expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) are produced by lentiviral transduction with TRAIL cDNA cloned into a...
DE102004017483B4 A method for isolating adult stem cells from differentiated tissue  
process for the isolation of adult stem cells from differentiated tissue, characterized in that - The tissue as gently crushed is, that the cell aggregates in the resulting tissue pieces remain...
DE102006020307A1 Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors  
Transgenic mesenchymal stem cells stably expressing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) are produced by retroviral transduction with TRAIL cDNA cloned into a...
DE112005003001T5 derived from human adipose multipotent stem cells and those containing cell therapeutics  
process for the production of adult stem cells, comprising culturing of human Adipose tissue-derived pellets in a medium containing N-acetyl-L-cysteine (NAC) and then collecting the cultured...
DE10347436B4 An in vitro method for diagnosing the cardiovascular functionality of blood-derived circulating precursor cells (BDP)  
In vitro method for Stratification of patients with cardiovascular disease and predicting the success of a progenitor cell therapy in patients with cardiovascular diseases said method comprising...
DE102006003996A1 Method for the formation of heart muscle cells (cardiomyocytes), useful e.g. in medical application, comprises culturing and differentiating stem cells, which are obtained from differentiated exocrine gland tissue of an organism  
Method for the formation of heart muscle cells (cardiomyocytes), comprises culturing and differentiating stem cells, which are obtained from differentiated exocrine gland tissue of an organism....
DE102006003854A1 Preparation of regulatory and cytotoxic CD8+ T cells, useful for treatment and prevention of immune reactions and associated disease, by treating naive cells with alpha-melanocyte-stimulating hormone  
Method for preparing regulatory and cytotoxic CD8+> T cells (A) comprises (a) providing naive T cells and (b) contacting them with alpha -MSH (alpha -melanocyte-stimulating hormone), or its...

Matches 1 - 50 out of 236 1 2 3 4 5 >